How Will The Cardiac Resynchronization Therapy Market Expand At A CAGR Of 6.2% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Cardiac Resynchronization Therapy Market?
The market size for cardiac resynchronization therapy has steadily expanded in the past few years. It is set to rise from $6.29 billion in 2024 to $6.72 billion in 2025, marking a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historical period include an increase in the elderly population, a rise in heart failure cases, escalating investments in R&D to innovate CRT devices, heightened consciousness about the advantages of the therapy, doctor training initiatives, and the dynamics of the competitive landscape.
In the coming years, the cardiac resynchronization therapy market is expected to experience significant growth. It is forecasted to develop into a $8.56 billion industry by 2029, with a compound annual growth rate (CAGR) of 6.2%. This marked development during the forecast period can be ascribed to the rising prevalence of heart disorders and cardiac ailments, the growing number of elderly individuals, an increase in the occurrence of cardiovascular diseases, the demand for CRT therapy, advancements in the treatment involving pacemakers and defibrillators, and an increased consciousness about CRT therapy. Key trends in the forecast period constitute the preference for CRT-D devices as opposed to conventional pacemakers, the incorporation of high-tech methodologies, the broadened application of CRT therapy, the introduction of artificial intelligence, and the employment of machine learning.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15531&type=smp
What Drivers Are Accelerating Expansion Of The Cardiac Resynchronization Therapy Market?
The rising incidence of cardiovascular diseases (CVD) is anticipated to stimulate the expansion of the cardiac resynchronization therapy (CRT) market in the future. The term CVD is used to describe a range of diseases that impact the heart and blood vessels. Various factors, such as aging populations, unhealthy lifestyles, increased tobacco consumption, inactive behavior, and poor diets, contribute to the surge in cardiovascular diseases. CRT aids CVD conditions like heart failure by facilitating better coordination of heart contractions via the dispensing of synchronized electrical pulses. For example, as per information released in September 2024 by the US-based Minnesota Department of Health, almost 30% of adults in Minnesota, equating to roughly 1.4 million individuals, were found to have high blood pressure in 2023; and in 2022, hypertensive diseases caused or contributed to the death of 14,225 residents, nearly 28% of the state’s total deaths. Consequently, the growing occurrence of cardiovascular diseases is a significant contributor to the advancement of the CRT market.
What Are The Primary Segmentation Parameters In The Cardiac Resynchronization Therapy Market?
The cardiac resynchronization therapymarket covered in this report is segmented –
1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator; Cardiac Resynchronization Therapy (CRT)-Pacemaker
2) By Age: Below 44 Years; 45-64 Years; 65-84 Years; Above 85 Years
3) By End-Use: Hospitals; Cardiac Care Centers; Ambulatory Surgical Centers
Subsegments:
1) By Cardiac Resynchronization Therapy (CRT)-Defibrillator: Single-Chamber CRT-D; Dual-Chamber CRT-D; Triple-Chamber CRT-D; Bi-Ventricular CRT-D
2) By Cardiac Resynchronization Therapy (CRT)-Pacemaker: Single-Chamber CRT-P; Dual-Chamber CRT-P; Triple-Chamber CRT-P; Bi-Ventricular CRT-P
How Are Industry Trends Steering The Expansion Of The Cardiac Resynchronization Therapy Market?
Leading firms in the cardiac resynchronization therapy market are focusing on the evolution of implantable devices to enhance the treatment results for heart failure patients. Such implantable devices used in cardiac resynchronization therapy (CRT) control the contractions of the heart’s ventricles, thereby increasing efficiency in pumping and regulating heart failure symptoms. An example is the MicroPort Scientific Corporation, a medical device company from China, which introduced the GALI SonR cardiac resynchronization therapy and defibrillator device (CRT-D), as well as the Navigo 4LV left ventricular pacing leads in Japan, in February 2024. This device is the first and sole CRT hemodynamic sensor made to automatically optimize patients on a weekly basis, most importantly, when the patient is active, permitting optimization in real-life scenarios. The established SonR algorithm, proven clinically, indicates a risk reduction of 35% in heart failure hospitalizations, and it also guarantees the safety and well-being of the CRT-D patient.
Which Players Are Shaping The Competitive Landscape Of The Cardiac Resynchronization Therapy Market?
Major companies operating in the cardiac resynchronization therapy market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Integer Holdings Corporation, Merit Medical Systems Inc., LivaNova PLC, MicroPort Scientific Corporation, Sorin Group, Berlin Heart GmbH, EBR Systems Inc., Corvia Medical Inc., Recor Medical, Jarvik Heart Inc., Cardiac Dimensions Inc., Farapulse Inc., Osypka Medical GmbH, Japan Medical Device Corporation, Imricor Medical Systems Inc., Vascular Dynamics Inc., Svelte Medical Systems, Aleva Neurotherapeutics, BioSig Technologies Inc.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Cardiac Resynchronization Therapy Market?
North America was the largest region in the cardiac resynchronization therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15531&type=smp
Browse Through More Reports Similar to the Global Cardiac Resynchronization Therapy Market 2025, By The Business Research Company
Vitamin D Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2025
Testosterone Replacement Therapy Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
